News AstraZeneca PLC

Equities

AZN

GB0009895292

Market Closed - London S.E. Other stock markets 11:35:17 2024-05-31 am EDT			5-day change	1st Jan Change
12,190 ^GBX	+1.35%		-1.73%	+15.00%

May. 31	Health Care Stocks Climb On Drug News -- Health Care Roundup	DJ
May. 31	Fusion Pharmaceuticals Gets Court Order Approving AstraZeneca Deal	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Health Care Stocks Climb On Drug News -- Health Care Roundup	May. 31	DJ
Fusion Pharmaceuticals Gets Court Order Approving AstraZeneca Deal	May. 31	MT
News Highlights: Top Company News of the Day - Friday at 1 PM ET	May. 31	DJ
News Highlights : Top Company News of the Day - Friday at 11 AM ET	May. 31	DJ
Battles over CEO pay across the globe	May. 31	RE
Goldman Sachs Starts AstraZeneca With Buy Rating, $97 Price Target	May. 30	MT
Goldman Sachs Kicks Off AstraZeneca Coverage at Buy	May. 30	MT
Jefferies and UBS cut Anglo American	May. 30	AN
Dr Martens cuts payout as profit plummets	May. 30	AN
ASTRAZENECA : Is no more a Sell but a Buy opportunity for Goldman Sachs	May. 30	ZD
Fusion Pharmaceuticals Shareholders Approve AstraZeneca Deal	May. 29	MT
AstraZeneca drug lowers cholesterol in phase 1 trial	May. 29	AN
Cellectis: operations financed until 2026	May. 29	CF
Astrazeneca Says AZD0780 Demonstrated Significant LDL-C Reduction On Top Of Statin In Phase I Trial	May. 29	RE
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment	May. 28	RE
Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval	May. 28	DJ
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Tuesday Trading	May. 28	MT
Daiichi Sankyo - Datopotamab deruxtecan showed clinically meaningful overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial	May. 28	AQ
Expansion of AstraZeneca's flagship health equity programme Healthy Heart Africa	May. 28	AQ
Expansion of AstraZeneca’s flagship health equity programme Healthy Heart Africa The programme aims to improve health outcomes, with a focus on increasing awareness of the symptoms and risks of hypertension	May. 28	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm EDT